GAD-7

General Anxiety Disorder Test


Start the test

  • Age range

    13+ years old

  • Question count

    7

  • Price

    $0

Overview

The Generalized Anxiety Disorder 7-item (GAD-7) Scale is a brief self-report tool designed to identify and measure the severity of generalized anxiety disorder (GAD). Developed by Dr. Robert L. Spitzer and his colleagues, the GAD-7 is widely used in both clinical and research settings due to its simplicity and strong psychometric properties. It is suitable for adults aged 18 and older and has been translated into numerous languages, facilitating its use in diverse populations worldwide.

Purpose

The primary purpose of the GAD-7 is to screen for GAD and to assess the severity of anxiety symptoms over the past two weeks. It helps healthcare providers make informed decisions regarding further diagnostic evaluation and potential treatment.

Structure

The GAD-7 consists of 7 items that reflect the core symptoms of GAD. Respondents rate each item based on how often they have been bothered by each symptom over the past two weeks. The responses are measured on a 4-point Likert scale ranging from 0 (not at all) to 3 (nearly every day).

Applications

  • Clinical Use: The GAD-7 is used by healthcare professionals to screen for generalized anxiety disorder, monitor changes in anxiety levels over time, and evaluate the effectiveness of treatment interventions.
  • Research Use: Researchers employ the GAD-7 to investigate the prevalence and impact of anxiety symptoms in various populations, as well as to examine the relationship between anxiety and other psychological or physiological conditions.

Psychometric Properties

The GAD-7 has demonstrated strong psychometric properties, making it a reliable and valid measure of anxiety severity.

Reliability

  • Internal Consistency: The GAD-7 exhibits high internal consistency, with Cronbach's alpha coefficients typically exceeding 0.90. This indicates that the items on the questionnaire reliably measure the same construct.
  • Test-Retest Reliability: The GAD-7 has shown good test-retest reliability, suggesting that it provides stable and consistent results over time.

Validity

  • Construct Validity: The GAD-7 has been validated through factor analyses, confirming its ability to measure the distinct construct of generalized anxiety disorder. It correlates well with other established measures of anxiety and related constructs.
  • Criterion Validity: The GAD-7 effectively differentiates between individuals with varying levels of anxiety severity, demonstrating its utility in identifying those with significant anxiety symptoms.

Benefits

The GAD-7 offers several advantages for clinicians and researchers:

  • Efficiency: The GAD-7 is a brief instrument that takes only a few minutes to complete, making it practical for routine use in busy clinical settings.
  • Accessibility: The GAD-7 is available in multiple languages and can be administered in various formats, including paper-and-pencil and electronic versions.
  • Versatility: The GAD-7 is suitable for use in a wide range of settings, including primary care, specialty clinics, and research environments.

Conclusion

The Generalized Anxiety Disorder 7-item (GAD-7) Scale is a valuable tool for assessing anxiety symptoms. Its strong psychometric properties, efficiency, and accessibility make it an essential resource for clinicians and researchers. By providing a comprehensive evaluation of anxiety severity, the GAD-7 contributes to better understanding, diagnosing, and managing generalized anxiety disorder, ultimately supporting effective interventions and therapeutic outcomes.

  • Category

    Anxiety Disorders, Generalized Anxiety Disorder, Stress

  • References

    Kroenke K, Spitzer RL, Williams JB, et al; Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection. Ann Intern Med. 2007:146(5):317-25.

    Löwe, B., Decker, O., Müller, S., Brähler, E., Schellberg, D., Herzog, W., & Herzberg, P. Y. (2008). Validation and standardization of the Generalized Anxiety Disorder Screener (GAD-7) in the general population. Medical care, 46(3), 266.

Ask our AI bot!

Online